VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 115 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,430,000 | -13.4% | 105,900 | -28.1% | 0.14% | -15.2% |
| Q2 2018 | $2,806,000 | -36.5% | 147,300 | -43.8% | 0.16% | -41.8% |
| Q1 2018 | $4,418,000 | -24.2% | 262,200 | -31.6% | 0.28% | -9.6% |
| Q4 2017 | $5,827,000 | -8.1% | 383,400 | +8.2% | 0.31% | -8.2% |
| Q3 2017 | $6,343,000 | +32.6% | 354,400 | +20.8% | 0.34% | +15.3% |
| Q2 2017 | $4,782,000 | +72.1% | 293,400 | +47.8% | 0.30% | +67.6% |
| Q1 2017 | $2,779,000 | +265.7% | 198,500 | +316.1% | 0.18% | +183.9% |
| Q4 2016 | $760,000 | +25.0% | 47,700 | -12.3% | 0.06% | +8.8% |
| Q2 2016 | $608,000 | -34.3% | 54,400 | -52.7% | 0.06% | -77.0% |
| Q2 2013 | $926,000 | – | 115,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |